comparemela.com
Home
Live Updates
Acurx Announces Scientific Oral and Poster Presentations at IDWeek : comparemela.com
Acurx Announces Scientific Oral and Poster Presentations at IDWeek
/PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of...
Related Keywords
United States ,
Washington ,
America ,
Davidp Luci ,
Kevin Garey ,
Medicine Association ,
Society For Healthcare Epidemiology Of America ,
Nasdaq ,
Development Update On Ibezapolstat ,
Acurx Pharmaceuticals Inc ,
Antimicrobial Drug Development ,
Acurx Pharmaceuticals ,
Prnewswire Acurx Pharmaceuticals Inc ,
Trial Oversight Committee ,
Drug Administration ,
Pediatric Infectious Diseases Society ,
Society Or Healthcare Epidemiology Of America ,
Exchange Commission ,
Exchange Commission On Form ,
University Of Houston College Pharmacy ,
Society Of Infectious Diseases Pharmacists ,
Infectious Diseases Society Of America ,
Infectious Disease Society Of America Idsa Idweek ,
Infectious Disease Society ,
Development Update ,
Houston College ,
Gram Positive Selective Spectrum ,
Poster Session ,
New Antimicrobial Drug Development ,
Qualified Infectious Disease Product ,
Generating New Antibiotic Incentives Now ,
Infectious Diseases Society ,
Healthcare Epidemiology ,
Infectious Diseases Pharmacists ,
Clinical Practice ,
New England Journal ,
Bile Acid ,
Ibezapolstat Phase ,
Scientific Advisory Board ,
Private Securities Litigation Reform Act ,
Nc ,
comparemela.com © 2020. All Rights Reserved.